Biomedical Engineering Reference
In-Depth Information
4. M. E. Tadros and M. D. Tucker. United States
Patent, 6,566,574, Formulations for neutralization
of chemical and biological toxants, May 20, 2003.
5. www.envirofoam.com.
6. www.deconsolutions.com.
7. www.usgn.com.
8. Modec, Inc., Technical Report, MOD2003-1012-G,
Formulations for the Decontamination and Miti-
gation of CB Warfare Agents, Toxic Hazardous
Materials, Viruses, Bacteria and Bacterial Spores,
February, 2003.
9. E. Rabner, et al. Decontamination issues for chem-
ical and biological warfare agents: how clean is
clean enough?, International Journal of Environ-
mental Health Research, 11, 128-148, 2001.
10. OSHA, Best Practices for Hospital-Based First
Receivers of Victims from Mass Casualty Inci-
dents involving Release of Hazardous Substances,
January, 2005.
11. S. Törngren, et al. Personal decontamination after
exposure to simulated liquid phase contaminants:
Functional assessment of a new unit,
Clinical Toxi-
cology
, 36(6):567-573, 1998.
12. R. S. Lindsay. Swatch Test Results of Commercial
Chemical Protective Gloves to Challenge by Chem-
ical Warfare Agents. Executive Summary, Soldier
and Biological Chemical Command, Department
of the Army, AMSSB-REN, Aberdeen Proving
Ground, MD, 2002.
13. www.radshield.com.
14. R. S. Lindsay and A. G. Pappas. Test Results of
Phase 3 Level A Suits to Challenge by Chem-
ical and Biological Warfare Agents and Similants:
Executive Summary, Soldier and Biological Chem-
ical Command, Department of the Army, AMSSB-
REN, Aberdeen Proving Ground, MD, 2002.
15. Pal, et al.
Journal of Hazardous Materials
,
33:123-141, 1993.
16. Sandia National Laboratories, 2003 and Modec,
Inc., http://www.deconsolutions.com/TIMS.htm
United States Army Medical Research Institute of
Chemical Defense, Bioscience 98, 1998.
